相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
Esteve Trias et al.
BONE MARROW TRANSPLANTATION (2022)
CRISPR-Cas9 gene editing induced complex on-target outcomes in human cells
Wei Wen et al.
EXPERIMENTAL HEMATOLOGY (2022)
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Alexander Dimitri et al.
MOLECULAR CANCER (2022)
CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
Ida Hoijer et al.
NATURE COMMUNICATIONS (2022)
Physiological lentiviral vectors for the generation of improved CAR-T cells
Maria Tristan-Manzano et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
Jaitip Tipanee et al.
MOLECULAR THERAPY (2022)
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies
Valentin Ortiz-Maldonado et al.
MOLECULAR THERAPY (2021)
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
Sergei Smirnov et al.
FRONTIERS IN IMMUNOLOGY (2021)
Advances in Universal CAR-T Cell Therapy
Haolong Lin et al.
FRONTIERS IN IMMUNOLOGY (2021)
Current Perspectives on Off-The-Shelf Allogeneic NK and CAR-NK Cell Therapies
Erica L. Heipertz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer
Lauren C. Cutmore et al.
CANCERS (2021)
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
Charlotte Elizabeth Graham et al.
LEUKEMIA (2021)
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Ehsan Razeghian et al.
STEM CELL RESEARCH & THERAPY (2021)
Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion
Wei Wen et al.
GENOME BIOLOGY (2021)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Stem Cell DNA Damage and Genome Mutation in the Context of Aging and Cancer Initiation
Lara Al Zouabi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger et al.
BLOOD (2020)
Cost of decentralizedCART-cell production in an academic nonprofit setting
Tao Ran et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Next-Generation Manufacturing Protocols Enriching TSCMCAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
Silvia Arcangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
Yuning Song et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Using Gene Editing Approaches to Fine-Tune the Immune System
Kristina Pavlovic et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin et al.
LANCET (2020)
Microhomologies are prevalent at Cas9-induced larger deletions
Dominic D. G. Owens et al.
NUCLEIC ACIDS RESEARCH (2019)
DNA double-strand break repair-pathway choice in somatic mammalian cells
Ralph Scully et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
Franziska Blaeschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
Akiko Seki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Long Terminal Repeat CRISPR-CAR-Coupled Universal T Cells Mediate Potent Anti-leukemic Effects
Christos Georgiadis et al.
MOLECULAR THERAPY (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Large deletions induced by Cas9 cleavage
Fatwa Adikusuma et al.
NATURE (2018)
Cas-analyzer: an online tool for assessing genome editing results using NGS data
Jeongbin Park et al.
BIOINFORMATICS (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
Daniel T. MacLeod et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A. Klebanoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation
Brian C. Shaffer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy
Madhusudhanan Sukumar et al.
CELL METABOLISM (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors
Hiroki Torikai et al.
MOLECULAR THERAPY (2016)
Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation
Nicolas Degauque et al.
FRONTIERS IN IMMUNOLOGY (2016)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina et al.
BLOOD (2014)
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
Drew C. Deniger et al.
CLINICAL CANCER RESEARCH (2014)
Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells
Patricia Graef et al.
IMMUNITY (2014)
Microhomology-based choice of Cas9 nuclease target sites
Sangsu Bae et al.
NATURE METHODS (2014)
A guide to genome engineering with programmable nucleases
Hyongbum Kim et al.
NATURE REVIEWS GENETICS (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Hiroki Torikai et al.
BLOOD (2012)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Janelle A. Olson et al.
BLOOD (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
分享论文
